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with return to OR for bleeding, primary graft dysfunction, longer
length of stay and increased resource utilization was reported [6].
Thus, it would be helpful, if more details on post-transplant com-
plications between groups could be provided. The survival data,
which are limited to an unadjusted Kaplan–Meier survival analysis
comparing conventional with lobar LTx, make it difﬁcult to inter-
pret the results in context. The lobar LTx group consisted predom-
inantly of patients with cystic ﬁbrosis, who in general have the
most favourable long-term survival. It would be informative if the
authors could show analysis within the same diagnostic groups (i.e.
cystic ﬁbrosis). Furthermore, providing a multivariate Cox propor-
tional hazard model adjusted for important confounders would
strengthen the assessment of clinical outcomes.
We wish to conclude by thanking and congratulating Inci et al.
on their important study on bilateral lobar LTx allowing life-saving
transplants in ‘short’ recipients, who otherwise might not be able
to receive an appropriately sized allograft in a timely way.
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We thank Eberlein et al. [1] for their interest in our article [2]. The
purpose of our study [2] was not to show that oversized grafts
are associated with more perioperative complications and worse
outcome compared with standard lung transplantation. In our
experience, oversized lung grafts can potentially lead to atelec-
tasis and impaired airway clearance, which leads to a more
complicated postoperative course [3]. Optimal size matching
is therefore very important. For optimal size matching, different
methods have been proposed, such as donor-recipient differ-
ence or ratio of body weight and height [4, 5]. In addition, chest
circumference and chest x-ray vertical and transverse dimensions
have been used [4]. Others have used donor and recipient
total lung capacity (TLC) [4, 5]. Interestingly, a recent US
study showed that overall post-transplant survival or lung func-
tion after standard lung transplantation was unaffected by
donor-to-recipient predicted TLC ratio and actual TLC ratio [6].
We also calculated donor-predicted TLC/recipient-predicted TLC
ratio (pTLC ratio) (Data not given in original article [2]). Median
pTLC ratio was 1.5 (range, 0.84–2.44). In only one recipient
this ratio was 0.84 and in all other 22 recipients, more than 1.
In addition, there is a very signiﬁcant correlation between pTLC
ratio and donor-recipient height difference (r = 0.903, P = 0.01,
Pearson correlation test) and also between pTLC ratio and
percentage of donor-recipient height discrepancy (r = 0.924, P =
0.01, Pearson correlation test). According to these data, it is also
possible and reliable to decide size mismatch with donor-
recipient height difference. We reported a rate of 39%
haemothorax requiring reoperation [2]. Nineteen (83%) of the
transplantations were performed with extracorporeal membrane
oxygenation (ECMO) support. Three recipients were on ECMO
preoperatively as a bridge to transplantation. This can explain
the rate of haemothorax requiring intervention. Detailed infor-
mation is given in our paper [2]. Our lobar transplant group are
not predominately cystic ﬁbrosis (CF) patients (n = 10). The
number of idiopathic pulmonary ﬁbrosis patients is 8 and nearly
equal to CF recipients.
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We read with interest the article ‘Red cell distribution width and
coronary artery bypass surgery’, by Warwick et al., [1]. They aimed
to investigate the effect of red cell distribution width (RDW)—after
adjustment for the haemoglobin level—on in-hospital mortality,
long-term survival, myocardial damage as assessed by creatine
kinase muscle–brain (CKMB) isoenzyme release and the length of
hospital and intensive care unit (ICU). They concluded that the
RDW was a signiﬁcant factor determining in-hospital mortality
and long-term survival, but that it had no signiﬁcant effect on
CKMB release or length of stay in ICU or hospital. Confounding
factor analysis revealed that, in the absence of anaemia, the RDW
was still a signiﬁcant factor determining in-hospital mortality and
long-term survival. They suggested that the RDW may be a signiﬁ-
cant factor determining in-hospital mortality and long-term
survival in patients undergoing isolated coronary artery bypass
graft (CABG). We believe that these ﬁndings will enlighten further
studies on the relationships between RDW and coronary artery
bypass surgery. Thanks to the authors for their contribution.
RDW has recently been identiﬁed as an independent predictor
of all-cause, long-term mortality in patients with coronary artery
disease [2]. Sometimes conditions like the differential diagnosis of
anaemias might affect the RDW parameter and so this parameter
might be changed in any such abnormality in thyroid function tests,
renal or hepatic dysfunction (creatinine >1.5 mg/dl, aspartate ami-
notransferase and alanine transaminase more than twice the upper
limit of normal, respectively), inﬂammatory diseases and any medi-
cation. On the other hand, it is also reported that an increased
RDW may be associated with ethnicity and nutritional deﬁciency
(i.e. iron, vitamin B12 and folic acid). Reduced glomerular ﬁltration
rate (GFR) may also be associated with adverse outcomes in patients
with cardiovascular disease. In a previous study, pre-operative GFR
was predictive of all-cause mortality, cardiovascular mortality and
combined cardiovascular mortality and morbidity. GFR may be
useful in identifying those patients undergoing CABG with subclin-
ical chronic kidney disease [3]. For this reason, it would be better if
the authors mentioned any of these possible conditions.
Present studies have shown that elevated levels of in-
ﬂammatory molecules are markers of atherosclerotic disease ac-
tivity. These molecules also indicate an increased risk of the
progression of CABG and they can be reduced by medications
such as antihypertensive therapy and acetylsalicylic acid treat-
ment [4, 5]. Additionally, not only RDW but also neutrophil
lymphocyte ratio, gamma-glutamyltransferase, C-reactive protein,
mean platelet volume and uric acid are markers easily used to
assess the cardiovascular disease of the patients [6]. These
markers might be useful in clinical practice. RDW itself, alone
without other inﬂammatory markers, may not give information to
clinicians about the inﬂammatory condition and prognostic indi-
cation of the patients. So we think that it should be evaluated to-
gether with other serum inﬂammatory markers. Finally, it would
be better if the authors deﬁned their timescale for measuring
RDW levels, because delay in blood sampling can cause abnormal
results in RDW measurements.
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